Kathleen DeRose - 27 Dec 2022 Form 4 Insider Report for Enfusion, Inc.

Role
Director
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
27 Dec 2022
Net transactions value
$0
Form type
4
Filing time
29 Dec 2022, 15:26:27 UTC
Previous filing
17 Jun 2022
Next filing
30 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +2,791 +9.6% $0.000000 32,013 27 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The RSUs will vest in full as follows: 931, 930 and 930 RSUs will vest on December 27, 2023, 2024 and 2025, respectively.

Remarks:

Exhibit 24 - Power of Attorney